Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/15770
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPopovic D.-
dc.contributor.authorKoufakis T.-
dc.contributor.authorKovacevic, Bojan-
dc.contributor.authorRIZZO, Manfredi-
dc.contributor.authorPapanas N.-
dc.date.accessioned2023-02-08T15:45:55Z-
dc.date.available2023-02-08T15:45:55Z-
dc.date.issued2022-
dc.identifier.issn1474-0338-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/15770-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourceExpert Opinion on Drug Safety-
dc.titleImmune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention-
dc.typeeditorial-
dc.identifier.doi10.1080/14740338.2022.2134343-
dc.identifier.scopus2-s2.0-85139867064-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

399

Downloads(s)

6

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.